Cumberland Pharmaceuticals (CPIX) Net Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Net Margin of 34.4% for Q1 2026, down 4505.0% on a YoY basis from 0.78% in Q1 2025, and down 232.42% sequentially from 10.35% in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Net Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 16 years of Net Margin data on file, last reported at 34.4% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 4505.0% year-over-year to 34.4%; the trailing twelve-month figure through Mar 2026 stood at 17.26% (down 925.0% YoY), and the FY2025 full-year result was 6.4%, up 1061.0% from the prior year.
- Net Margin slipped to 34.4% in Q1 2026, from 10.35% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 10.66% in Q1 2025 to a low of 67.38% in Q4 2023.
- A 4-year average of 15.48% and a median of 11.2% in 2024 frame the typical range for Net Margin.
- Across the five-year window, Net Margin jumped 4916 bps in 2024 and sank 4505 bps in 2026, its largest moves.
- Tracing CPIX's Net Margin over 4 years: stood at 67.38% in 2023, then surged by 73 bps to 18.22% in 2024, then jumped by 43 bps to 10.35% in 2025, then sank by 232 bps to 34.4% in 2026.
- Business Quant data shows CPIX's Net Margin at 34.4% in Q1 2026, 10.35% in Q4 2025, and 23.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | -34.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.40% |
| Dec 31, 2025 | -10.35% |
| Sep 30, 2025 | -23.50% |
| Jun 30, 2025 | -6.78% |
| Mar 31, 2025 | 10.66% |
| Dec 31, 2024 | -18.22% |
| Sep 30, 2024 | -16.92% |
| Jun 30, 2024 | -11.20% |
| Mar 31, 2024 | -22.39% |
| Dec 31, 2023 | -67.38% |
| Sep 30, 2023 | -10.54% |
| Jun 30, 2023 | 7.92% |
| Mar 31, 2023 | 1.87% |
| Dec 31, 2021 | 6.05% |
| Sep 30, 2021 | 6.15% |
| Jun 30, 2021 | 5.51% |
| Mar 31, 2021 | 4.70% |
| Dec 31, 2020 | 8.50% |
| Sep 30, 2020 | 8.41% |
| Jun 30, 2020 | 7.70% |